658 related articles for article (PubMed ID: 24399815)
1. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
[TBL] [Abstract][Full Text] [Related]
2. Association between butyrylcholinesterase activity and phenotypes, paraoxonase192 rs662 gene polymorphism and their enzymatic activity with severity of rheumatoid arthritis: correlation with systemic inflammatory markers and oxidative stress, preliminary report.
Shahmohamadnejad S; Vaisi-Raygani A; Shakiba Y; Kiani A; Rahimi Z; Bahrehmand F; Shakiba E; Pourmotabbed T
Clin Biochem; 2015 Jan; 48(1-2):63-9. PubMed ID: 25179377
[TBL] [Abstract][Full Text] [Related]
3. Synergism between apolipoprotein E Ɛ4 allele and paraoxonase (PON1) 55-M allele is associated with risk of systemic lupus erythematosus.
Tanhapour M; Miri A; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Pourmotabbed T; Shakiba E
Clin Rheumatol; 2018 Apr; 37(4):971-977. PubMed ID: 29273831
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase (PON1) 55 polymorphism and association with systemic lupus erythematosus.
Bahrehmand F; Vaisi-Raygani A; Ahmadi R; Kiani A; Rahimi Z; Tavilani H; Pourmotabbed T
Iran J Allergy Asthma Immunol; 2013 Jul; 12(3):211-9. PubMed ID: 23893804
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress.
Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Ardalan M; Vaisi-Raygani H; Shakiba E; Pourmotabbed T
Lupus; 2015 May; 24(6):597-605. PubMed ID: 25416694
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients.
Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Navabi SJ; Shakiba E; Hassanzadeh N; Pourmotabbed T
Lupus; 2012 May; 21(6):616-24. PubMed ID: 22323339
[TBL] [Abstract][Full Text] [Related]
8. Association between activity and genotypes of paraoxonase1 L
Tanhapour M; Shahmohamadnejad S; Vaisi-Raygani A; Kiani A; Shakiba Y; Rahimi Z; Bahrehmand F; Shakiba E; Vaisi-Raygani AA; Alibakhshi R; Eivazi A; Pourmotabbed T
Mol Biol Rep; 2019 Feb; 46(1):741-749. PubMed ID: 30506510
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin type 1 receptor A1166C polymorphism and systemic lupus erythematosus: correlation with cellular immunity and oxidative stress markers.
Baniamerian H; Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Pourmotabbed T
Lupus; 2017 Dec; 26(14):1534-1539. PubMed ID: 28530466
[TBL] [Abstract][Full Text] [Related]
10. Relationship Between Paraoxonase-1 and Butyrylcholinesterase Activities and Nutritional Status in Mexican Children.
Ramírez-Jiménez R; Martínez-Salazar MF; Almenares-López D; Yáñez-Estrada L; Monroy-Noyola A
Metab Syndr Relat Disord; 2018 Mar; 16(2):90-96. PubMed ID: 29393817
[TBL] [Abstract][Full Text] [Related]
11. Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt.
Ibrahim AA; El-Lebedy D; Ashmawy I; Hady MA
Clin Rheumatol; 2017 Jun; 36(6):1305-1310. PubMed ID: 28185016
[TBL] [Abstract][Full Text] [Related]
12. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus.
Gaál K; Tarr T; Lőrincz H; Borbás V; Seres I; Harangi M; Fülöp P; Paragh G
Lipids Health Dis; 2016 Mar; 15():60. PubMed ID: 27004558
[TBL] [Abstract][Full Text] [Related]
13. Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma.
Malik UU; Siddiqui IA; Hashim Z; Zarina S
Clin Chim Acta; 2014 Mar; 430():38-42. PubMed ID: 24389054
[TBL] [Abstract][Full Text] [Related]
14. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation.
Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A
Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476
[TBL] [Abstract][Full Text] [Related]
15. Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients.
AnandBabu K; Bharathidevi SR; Sripriya S; Sen P; Prakash VJ; Bindu A; Viswanathan N; Angayarkanni N
Exp Eye Res; 2016 Nov; 152():100-112. PubMed ID: 27693409
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance is related with oxidative stress in systemic lupus erythematosus.
Koca SS; Karaca I; Yavuzkir MF; Dağli N; Ozgen M; Ustündağ B; Işik A
Anadolu Kardiyol Derg; 2009 Feb; 9(1):23-8. PubMed ID: 19196569
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase (PON1) polymorphism & its relation with lipids in north west Indian Punjabis.
Singh S; Verma M; Nain CK; Leelamma CO; Goel RC
Indian J Med Res; 1999 Oct; 110():133-7. PubMed ID: 10645101
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase status and plasma butyrylcholinesterase activity in chlorpyrifos manufacturing workers.
Albers JW; Garabrant DH; Berent S; Richardson RJ
J Expo Sci Environ Epidemiol; 2010 Jan; 20(1):79-89. PubMed ID: 19223938
[TBL] [Abstract][Full Text] [Related]
19. Association between the cytotoxic T-lymphocyte antigen-4 mutations and the susceptibility to systemic lupus erythematosus; Contribution markers of inflammation and oxidative stress.
Tanhapour M; Vaisi-Raygani A; Bahrehmand F; Khazaei M; Kiani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):56-61. PubMed ID: 27894401
[TBL] [Abstract][Full Text] [Related]
20. Paraoxonase activity in healthy, diabetic, and hemodialysis patients.
Gbandjaba NY; Ghalim N; Hassar M; Berrougui H; Labrazi H; Taki H; Saile R; Khalil A
Clin Biochem; 2012 Apr; 45(6):470-4. PubMed ID: 22285382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]